HOME >> BIOLOGY >> NEWS
Annual bibliography of significant advances in dietary supplement research 2002

The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) announces the release of the fourth issue of the Annual Bibliography of Significant Advances in Dietary Supplement Research. This publication presents significant research in the dietary supplement field for the year 2002.

"ODS is pleased to release the 2002 Bibliography. The response to previous issues has been so positive that we are continuing the series with a fourth edition," said Paul M. Coates, Ph.D., Director of ODS. "Interest and use of dietary supplements continues to be prevalent in the United States population, and this bibliography provides an excellent opportunity to give well-deserved recognition to those scientists conducting scientific research on these products."

For the 2002 issue of the Annual Bibliography, there were over 350 original research articles nominated from 34 peer-reviewed journals. An international team of 45 expert reviewers in the fields of nutrition and botanical sciences and public health reviewed and ranked the articles. The top 25 articles were selected for publication.

The articles for the 2002 bibliography included research in the following areas:

  • Antioxidants;
  • Vitamins;
  • Minerals;
  • Amino acids and fatty acids;
  • Botanicals;
  • Fiber; and
  • Soy

The 2002 Bibliography includes an index of citations of papers from the 2001 and 2000 Annual Bibliographies. This feature, introduced with the 2001 issue, allows the reader to see developments in dietary supplement research over the last three years. "Listing previous year's citations in each issue provides a snap-shot of the science for that year," said Leila Saldanha, Ph.D., R.D., co-editor of the publication. "This year's issue, for example, features a number of intervention studies that examined the role of vitamin E in management of heart disease".

"We envision that this bibliography will serve as a
'"/>

Contact: Kelli Marciel
marcielk@od.nih.gov
301-496-4819
NIH/Office of the Director
27-Oct-2003


Page: 1 2

Related biology news :

1. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
2. Popular Science announces Third Annual Brilliant 10
3. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
4. ESA 89th Annual Meeting
5. Organization for Human Brain Mapping 2004 Annual Meeting
6. Annual Chemical Biology Symposium at Yale May 14, 2004
7. AIUM to honor ultrasound pioneers at its 2004 Annual Convention
8. National Academies advisory: NAS Annual Meeting April 17-20
9. Society of Nuclear Medicines 51st Annual Meeting June 19-23, 2004
10. Annual bioethics forum to explore genetic testing
11. Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting

Post Your Comments:
(Date:5/5/2015)... OXFORD, Conn. , May 5, 2015, NXT-ID, ... biometric authentication company focused on the growing mobile commerce market, ... the Company,s Chief Technology Officer, is presenting  at CARTES SECURE ... May 5-7, 2015. The three-day conference ... session David is speaking in is themed Global Fraud: ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial Hospital ... to implant a new miniaturized, wireless monitoring sensor to ... the first and only FDA-approved heart failure monitoring device ... when used by physicians to manage heart failure. ... is implanted in the pulmonary artery (PA) during a ...
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
(Date:5/28/2015)... 28, 2015 ... announced the addition of Jain PharmaBiotech,s ... Markets and Companies"  to their offering.  ... describes and evaluates animal biotechnology and ... pharmaceuticals as well as improvement in ...
(Date:5/28/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/3nl6s2/neuroprotection ) ... report "Neuroprotection - Drugs, Markets and Companies" ... describes the role of neuroprotection in acute disorders ... system as well as in chronic diseases such ... mechanisms of damage to neural tissues are similar ...
(Date:5/28/2015)... Texas (PRWEB) May 28, 2015 ... for use in applications such as animal waste ... and oil reduction in wastewater treatment plants and ... attending the World Pork Expo, June 3-5 in ... this year in a Wall Street Journal article ...
(Date:5/28/2015)... MIAMI BEACH, Fla. , May 28, 2015 /PRNewswire/ ... data supporting the anti-cancer potential of its growth hormone-releasing ... presentation at the 2015 ASCO Annual Meeting. The ... the target for Biscayne,s anti-cancer GHRH blockers, is present ... receptor status. These findings suggest that GHRH antagonists could ...
Breaking Biology Technology:Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 3Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 3DryLet to Showcase Patented ManureMagicâ„¢ at the 2015 World Pork Expo, June 3-5 in Des Moines, Iowa 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 3
Cached News: